$3bln valuation

The pharmaceutical companies—multination and local—are always in the limelight in Pakistan mainly for the wrong reasons.  Such as the shortage of high-demand medicines during outbreak of different diseases, the staggering jump in the prices of different medicines, and the counterfeit sale of medicines. Despite these challenges in the densely populated country of South Asia, pharmaceutical…